Suppr超能文献

女性垂体催乳素分泌腺瘤。II. 显微手术切除后的月经功能、垂体储备及催乳素分泌

Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal.

作者信息

Keye W R, Chang R J, Monroe S E, Wilson C B, Jaffe R B

出版信息

Am J Obstet Gynecol. 1979 Jun 15;134(4):360-5. doi: 10.1016/s0002-9378(16)33076-9.

Abstract

A prospective study of 46 women with prolactin-secreting pituitary adenomas and amenorrhea and/or galactorrhea was performed to determine the influence of the selective transsphenoidal removal of these tumors on pituitary and reproductive function. This procedure was effective in restoring menstrual function in 34 of 41 women and in eliminating lactation in 30 of 40 women. Tumor size and preoperative serum prolactin concentrations were the most important factors in predicting the postoperative disappearance of symptoms. Normal menstrual function returned in 33 of 34 women with tumors less than 2 cm in diameter but in only one of seven women with tumors greater than 2 cm. Similarly, galactorrhea disappeared in 29 of 34 women with tumors less than 2 cm but in only one of six women with larger tumors. Menses returned in 31 of 32 women and galactorrhea disappeared in 25 of 31 women with preoperative serum prolactin levels below 200 ng/ml; conversely, menses returned in only three of nine women and lactation ceased in one of six women with preoperative serum prolactin concentrations above 200 ng/ml. Prolactin concentrations decreased in 42 of 43 patients following the removal of pituitary adenomas and returned to normal in 30. Postoperative pituitary reserves of adrenocorticotropic hormone, growth hormone, luteinizing hormone, and follicle-stimulating hormone were normal in most patients. These data indicate that the removal of prolactin-secreting pituitary adenomas by a neurosurgeon accomplished in this surgical technique is effective in restoring menstrual function and eliminating lactation in most women, especially if the tumor is less than 2 cm in diameter and the preoperative serum prolactin concentration is less than 200 ng/ml.

摘要

对46例患有分泌催乳素的垂体腺瘤且伴有闭经和/或溢乳的女性进行了一项前瞻性研究,以确定选择性经蝶窦切除这些肿瘤对垂体和生殖功能的影响。该手术在41例女性中有34例恢复了月经功能,在40例女性中有30例消除了泌乳。肿瘤大小和术前血清催乳素浓度是预测术后症状消失的最重要因素。直径小于2 cm的肿瘤患者中,34例有33例恢复了正常月经功能,而直径大于2 cm的7例患者中只有1例恢复正常月经。同样,直径小于2 cm的肿瘤患者中,34例有29例溢乳消失,而肿瘤较大的6例患者中只有1例溢乳消失。术前血清催乳素水平低于200 ng/ml的32例女性中有31例月经恢复,31例中有25例溢乳消失;相反,术前血清催乳素浓度高于200 ng/ml的9例女性中只有3例月经恢复,6例中有1例泌乳停止。43例患者中42例在切除垂体腺瘤后催乳素浓度下降,30例恢复正常。大多数患者术后垂体促肾上腺皮质激素、生长激素、黄体生成素和卵泡刺激素的储备正常。这些数据表明,通过这种手术技术由神经外科医生切除分泌催乳素的垂体腺瘤,对大多数女性恢复月经功能和消除泌乳是有效的,特别是如果肿瘤直径小于2 cm且术前血清催乳素浓度小于200 ng/ml。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验